PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 14, 2026Stem Cell Research & Therapy0 citationsOpen Access

TSPO governs bone-lipid homeostasis by redirecting BMSC differentiation via the PI3K/AKT/β-catenin pathway

PZPeng ZhangFujian Medical UniversityHZHongyu ZhengShandong University of TechnologyZLZhao LinFujian Medical University

Key Points

  • The research aims to clarify the role of TSPO in bone and lipid regulation and its impact on osteogenesis.
  • Analysis of TSPO's effects on BMSC (Bone Marrow Stem Cell) differentiation
  • Investigation of the PI3K/AKT/β-catenin signaling pathway
  • Evaluation of TSPO targeting as a potential therapeutic intervention for osteoporosis.
  • TSPO disruption negatively affects osteogenesis
  • Targeting TSPO may enhance bone formation
  • Intervention shows potential to address osteoporosis through anabolic mechanisms.

Abstract

Our study identifies TSPO as a key pathogenic regulator that impairs osteogenesis by disrupting the PI3K/AKT/β-catenin pathway. Targeting TSPO presents a novel anabolic strategy for osteoporosis, potentially addressing the unmet clinical need for therapies that restore bone formation.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Zhang et al. (2026) studied this question.

synapsesocial.com/papers/69b4fc44b39f7826a300cfe7https://doi.org/10.1186/s13287-026-04948-z
Ask AI
Helpful
Bookmark
Share
View Full Paper